Skip to main content
Clinical Trials/NCT01664832
NCT01664832UnknownNot Applicable

Is Synchronization More Effective During Noninvasive Ventilation in Immediately Extubated Preterm Infants?

Prof. Dr. Helmut Hummler2 sites in 1 country18 target enrollmentStarted: July 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
18
Locations
2
Primary Endpoint
phasic esophageal pressure deflection

Study Overview

Brief Summary

The purpose of this study is the examination of the hypothesis that synchronized nasal IMV as compared to non-synchronized nasal IMV will decrease breathing effort in preterm infants immediately after extubation when recovering from Respiratory distress syndrome (RDS).

Another objective is to examine the effects for synchronized non-invasive mechanical ventilation on gas exchange and cerebral oxygen saturation.

Detailed Description

In this study the investigators plan to test the hypothesis that synchronized nasal IMV (S-NIMV) as compared to non-synchronized nasal IMV (NIMV) will decrease breathing effort in preterm infants immediately after extubation when recovery from RDS, as measured by phasic esophageal pressure deflection.

Furthermore, the investigators plan to evaluate the effects of synchronized NIMV on gas exchange and brain oxygenation, and to evaluate the reliability of a newly developed abdominal pressure sensor device for the S-NIMV mode in a newly designed commercially available ventilator device.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Preterm infants recovering from respiratory failure with the following criteria were eligible for this study.
  • Gestational age <32 wks, those who are on invasive mechanical ventilation, recovering from RDS, and ready for extubation as judged by the clinical team.
  • Informed consent available.

Exclusion Criteria

  • Infants with major congenital anomalies involving the CNS, lung (i.e. lung hypoplasia, active air leaks) or the heart (ASD, VSD allowed), or known neuromuscular disease.

Outcomes

Primary Outcomes

phasic esophageal pressure deflection

Time Frame: 4 hours

Secondary Outcomes

  • Cerebral oxygen saturation(4 hours)
  • Arterial oxygen saturation(4 hours)

Investigators

Sponsor
Prof. Dr. Helmut Hummler
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Prof. Dr. Helmut Hummler

Prof. Dr. Helmut Hummler

University of Ulm

Study Sites (2)

Loading locations...

Similar Trials